Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Pneumococcal vaccination in the elderly: an underused option?P O Honkanen, P H MäkeläArchives of Internal Medicine|January 22, 1996
Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderlyP O Honkanen, T Keistinen, S L KiveläPublic Health|May 1, 1996
Factors associated with influenza vaccination coverage among the elderly: role of health care personnelP O Honkanen, T Keistinen, S L KivelaVaccine|February 1, 1997
The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly populationP O Honkanen, T Keistinen, S L KiveläVaccine|July 1, 1997
Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderlyU Sankilampi, P O Honkanen, R Pyhälä, et al.The Journal of Infectious Diseases|October 23, 1997
Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderlyU Sankilampi, P O Honkanen, A Bloigu, et al.Central European Journal of Public Health|March 1, 1997
Hospitalization for pneumonia in the Finnish working-age populationP Säynäjäkangas, T Keistinen, P O Honkanen, et al.Age and Ageing|July 1, 1997
Hospital discharges for pneumonia in Finland between 1972 and 1993 in the population aged 65 years or overP Säynäjäkangas, T Keistinen, P O Honkanen, et al.Archives of Internal Medicine|December 26, 2001
Severity assessment of lower respiratory tract infection in elderly patients in primary careY Seppä, A Bloigu, P O Honkanen, et al.The Journal of Infectious Diseases|February 1, 1996
Antibody response to pneumococcal capsular polysaccharide vaccine in the elderlyU Sankilampi, P O Honkanen, A Bloigu, et al.Pageof 2